Clinical Trials Logo

Chronic Inflammatory Syndrome clinical trials

View clinical trials related to Chronic Inflammatory Syndrome.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT00978224 Suspended - Clinical trials for Chronic Inflammatory Syndrome

Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment

Start date: October 2009
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine whether Viusid administration improves malnutrition, atherosclerosis, erythropoietin response and the frequency of infection episodes in subjects with Chronic Inflammatory Syndrome under hemodialysis treatment. The duration of this double-blind placebo controlled phase 3 clinical trial will be 60 weeks. All patients enrolled in the study will be receiving the standard treatment for Chronic Inflammatory Syndrome including hemodialysis and administration of a hypercaloric and hyperproteic diet. Efficacy assessment will be carried out 12 weeks after the end of Viusid or placebo treatment.